Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru Hanganu

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Movement Disorders Clinical Practice|August 4, 2025
The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive AssessmentGabriel D Pinilla-Monsalve, Yuan P Song, Alexandru Hanganu, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 28, 2026
Distinct motor cortex interneuron plasticity and its association with prefrontal brain volume in Parkinson's diseaseAmanda O'Farrell, Nesrine Harroum, Amina El-Housseini, et al.
Neuroimage. Clinical|December 29, 2022
Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thicknessHannes Almgren, Alexandru Hanganu, Milton Camacho, et al.
Brain Topography|February 4, 2014
Cortical Thickness Changes Associated with Photoparoxysmal ResponseAlexandru Hanganu, Stanislav A Groppa, Günther Deuschl, et al.
Scientific Reports|August 14, 2023
Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal featuresHannes Almgren, Milton Camacho, Alexandru Hanganu, et al.
Plos One|February 14, 2017
Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin TherapyAlexandru Hanganu, Muthuraman Muthuraman, Venkata Chaitanya Chirumamilla, et al.
Brain Communications|October 9, 2025
Apathy progression is associated with brain atrophy and white matter damage in Parkinson's diseaseRoqaie Moqadam, Houman Azizi, Aliza Brzezinski-Rittner, et al.
Frontiers in Neurology|October 14, 2014
Influence of depressive symptoms on dopaminergic treatment of Parkinson's diseaseAlexandru Hanganu, Clotilde Degroot, Oury Monchi, et al.
Brain and Cognition|December 6, 2016
Depressive symptoms in Parkinson's disease correlate with cortical atrophy over timeAlexandru Hanganu, Marie-Andrée Bruneau, Clotilde Degroot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 27, 2013
Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degenerationAlexandru Hanganu, Christophe Bedetti, Thomas Jubault, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Movement Disorders Clinical Practice|August 4, 2025
The Mild Behavioral Impairment Checklist for Parkinson's Disease: An Ancillary Instrument in Cognitive AssessmentGabriel D Pinilla-Monsalve, Yuan P Song, Alexandru Hanganu, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 28, 2026
Distinct motor cortex interneuron plasticity and its association with prefrontal brain volume in Parkinson's diseaseAmanda O'Farrell, Nesrine Harroum, Amina El-Housseini, et al.
Neuroimage. Clinical|December 29, 2022
Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thicknessHannes Almgren, Alexandru Hanganu, Milton Camacho, et al.
Brain Topography|February 4, 2014
Cortical Thickness Changes Associated with Photoparoxysmal ResponseAlexandru Hanganu, Stanislav A Groppa, Günther Deuschl, et al.
Scientific Reports|August 14, 2023
Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal featuresHannes Almgren, Milton Camacho, Alexandru Hanganu, et al.
Plos One|February 14, 2017
Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin TherapyAlexandru Hanganu, Muthuraman Muthuraman, Venkata Chaitanya Chirumamilla, et al.
Brain Communications|October 9, 2025
Apathy progression is associated with brain atrophy and white matter damage in Parkinson's diseaseRoqaie Moqadam, Houman Azizi, Aliza Brzezinski-Rittner, et al.
Frontiers in Neurology|October 14, 2014
Influence of depressive symptoms on dopaminergic treatment of Parkinson's diseaseAlexandru Hanganu, Clotilde Degroot, Oury Monchi, et al.
Brain and Cognition|December 6, 2016
Depressive symptoms in Parkinson's disease correlate with cortical atrophy over timeAlexandru Hanganu, Marie-Andrée Bruneau, Clotilde Degroot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 27, 2013
Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degenerationAlexandru Hanganu, Christophe Bedetti, Thomas Jubault, et al.
Pageof 4